ArticlePneumonia (Nathan Qld.)2024

Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to Afatinib.

Jie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.